)

Lipocine (LPCN) investor relations material
Lipocine Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Focused on oral drug delivery for CNS, liver, and hormone disorders, with a pipeline including LPCN 1154 (postpartum depression), LPCN 2401 (obesity/GLP-1 adjunct), LPCN 2101 (epilepsy), and others.
Initiated pivotal Phase 3 trial for LPCN 1154 in postpartum depression, with topline results expected Q2 2026 and NDA submission planned for mid-2026.
Advanced LPCN 2401 for obesity management, with Phase 2 study in GLP-1 eligible patients to begin Q3 2025.
Commercialization of TLANDO (oral testosterone) through multiple licensing agreements in the US, Canada, South Korea, GCC, and Brazil, with milestone and royalty revenue potential.
Seeking partners for further development and commercialization of pipeline assets.
Financial highlights
Q2 2025 revenue was $623K, up from $90K in Q2 2024, driven by $500K license revenue and $123K royalty revenue.
Net loss for Q2 2025 was $2.2M ($0.41/share), improved from $3.1M ($0.57/share) in Q2 2024; six-month net loss was $4.1M ($0.76/share) vs. net income of $445K ($0.10/share) in prior year, which included a $7.5M license payment.
R&D expenses rose to $2.1M in Q2 2025, mainly due to LPCN 2401 study initiation; G&A expenses fell to $0.9M.
Cash, cash equivalents, and marketable securities totaled $17.9M as of June 30, 2025, down from $21.6M at year-end 2024.
Outlook and guidance
Current capital resources expected to fund operations through at least August 2026, including ongoing clinical trials.
Topline results for LPCN 1154 Phase 3 trial expected Q2 2026; NDA submission planned for mid-2026.
Additional capital will be needed for expanded development or if milestones are not met; potential sources include equity, debt, or out-licensing.
Next Lipocine earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage